Oklahoma Medical Research Foundation

Students participated in the 23rd Festival of Science, Technology, and Art in Łódź and organized workshops. Two research projects were published in Web of Science-indexed journals: one on endophytic bacteria from stinging nettle and another on bacterial regulatory proteins. inż. Jakub Filipek received a Fulbright scholarship for a research internship in the U.S., following inż. Aleksandra Kośmider's footsteps.

Autoimmune diseases result from immune cells mistakenly attacking the body's own cells, leading to the production of autoantibodies. Judith James and other scientists aim to identify early biomarkers to prevent disease onset. Teplizumab, approved by the FDA in 2022, delays type 1 diabetes onset in children, inspiring hope for similar treatments in other autoimmune diseases. Researchers face challenges in understanding disease risk and developing non-toxic preventative treatments. Progress is being made, but the complexity of the immune system complicates prevention efforts.

Precision medicine in rheumatology aims to tailor treatments based on individual patient's molecular profiles, addressing the heterogeneity in systemic autoimmune rheumatic diseases (SARDs). Advances in omic technologies enable patient stratification for optimized outcomes and identification of new therapeutic pathways. Challenges include the complexity of SARDs, the need for precise treatment response measures, and the integration of molecular stratification into clinical care.